Methods of identifying morphogen receptor-binding analogs

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S007200

Reexamination Certificate

active

07067260

ABSTRACT:
Disclosed are (1) nucleic acid sequences, amino acid sequences, homologies, structural features and various other data characterizing a morphogen cell surface receptors particularly OP-1-binding cell surface receptors; (2) methods for producing receptor proteins, including fragments thereof, using recombinant DNA technology; (3) methods for identifying novel morphogen receptors and their encoding DNAs; (4) methods and compositions for identifying compounds capable of modulating endogenous morphogen receptor levels; and (5) methods and compositions for identifying morphogen receptor binding analogs useful in the design of morphogen agonists and antagonists for therapeutic, diagnostic and experimental uses.

REFERENCES:
patent: 5434067 (1995-07-01), Michaelis et al.
patent: 5538892 (1996-07-01), Donahoe et al.
patent: WO 90/05802 (1991-05-01), None
patent: WO 91/05802 (1991-05-01), None
patent: WO 93/05172 (1993-03-01), None
patent: WO 93/19177 (1993-09-01), None
patent: WO 94/11502 (1994-05-01), None
patent: WO 95/07982 (1995-03-01), None
patent: WO 95/14778 (1995-06-01), None
Stratagene Catalog, p. 39, 1988.
Attisano et al. Identification of Human Activin & TGF-β . . . with Type II Receptors.Cell75, 671-680 (1993).
Bassing et al. A Transforming Growth Factor β Type I Receptor . . . Gene Expression.Science263, 87-89 (1994).
Cagan et al. The role of induction in cell choice and cell cycle in the developing drosophila retina.Molecular Basis of Morphogenesis.M. Bernfield, ed. Wiley-Liss, N.Y., 109-133 (1993).
Childs et al. Identification of a Drosophila Activin Receptor.PNAS90. 9475-9479 (1993).
Ebner et al. Cloning of a Type 1 TGF-β Receptor and Its Effect on TGF-β Binding to the Type II Receptor.Science260, 1344-1348 (1993).
Ebner et al. Determination of Type 1 Receptor Specificity by the Type II Receptors for the TGF-β or Activin.Science262, 900-902 (1993).
Estevez et al. The daf-4 Gene Encodes a Bone Morphogenetic . . . Dauer Larva Development.Nature365, 644-649 (1993).
Frazen et al. Cloning of a TGF-β Type I Receptor that Forms a Heteromeric Complex with the TGF-62 Type II Receptor.Cell75. 681-692 (1993).
Gibbs, W. More fun than a root canal.Scientific Am.269, 106 (Nov. 1993).
He et al. Development Expression of Four Novel Serine/Threonine Kinase . . . Type II Receptor Family.Development Dynamics196, 133-142 (1993).
Inagaki et al. Growth Inhibition by Transforming Growth Factor βType I . . . TGF-β Receptor Type II cDNA.PNAS90, 5359-5363 (1993).
Kawabata et al. Cloning of a Novel Type II Serine/Threonine Kinase Receptor Through Interaction with the Type I Transforming Growth Factor-β Receptor.J. Biol. Chem.270, 5625-5630 (1995).
Koenig et al. Characterization and Cloning of a Receptor for BMP-2 and BMP-4 from NIH 3T3 Cells.Mol. Cell. Biol.14, 5961-5974 (1994).
Lin et al. Receptors for the TGF-β Superfamily: Multiple Polypeptides and Serine/Threonine Kinases.Cell3, 14-25 (1993).
Massague. Receptors for the TGF-β Family.Cell69, 1067-1070 (1992).
Mathews et al. Cloning of a Second Type of Activin Receptor and Functional Characterization in Xenopus Embryos.Science255, 1702-1705 (1992).
Matsuzaki et al. A Widely Expressed Transmembrane Serine/Threonine Kinase . . . Bone Morphogenic Factor.J. Biol. Chem.268, 12719-12722 (1993).
Paralkar et al. Identification and Characterization of Cellular Binding Proteins . . . Bone Differentiation Cascade.PNAS88, 3397-3401 (1991).
Sampath et al. Recombinant human ostegenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine ostogenic protein and stimulates osteoblast proliferation and differentiation in vitro.J. Biol. Chem.(Oct. 1992), 267(28): 20352-20362.
Short Protocols in Molecular Biology. Ausubel et al., eds. John Wiley & Sons, N.Y. 185-191 (1989).
Strader et al. Structural basis of beta-adrenergic receptor function.FASEB J.3, 1825-1832 (1989).
ten Dijke et al. Activin Receptor-Like Kinases: A Novel Subclass of Cell Surface Receptors with Predicted Serine/Threonine Kinase Activity.Oncogene8, 2879-2887 (1993).
ten Dijke et al. Characterization of Type I Receptors for Transforming Growth Factor-β and Activin.Science264, 101-103 (1994).
ten Dijke et al. Identification of Type I Receptors for Osteogenic Protein-1 and Bone Morphogenetic Protein-4.J. Biol. Chem.269, 16985-16988 (1994).
Thompson et al. Vargula hilgendorfii luciferase: a secreted reporter enzyme for monitoring gene expression in mammalian cells.Gene96, 257-262 (1990).
Tsuchida et al. Cloning and Characterization of a Transmembrane Serine Kinase . . . Type I Receptor.PNAS90, 11242-11246 (1993).
Vukicevic et al. Localization of Ostogenic Protein-1 (Bone Morphogenetic Protein-7) During Human Embryonic Development: High Affinity Binding to Basement Membranes.Biochem.&Biophys. Res. Comm.198, 693-700 (1994).
Wrana et al. TGF-β Signals Through a Heteromeric Protein Kinase Receptor Complex.Cell71, 1003-1014 (1992).
Yamaji et al. The molecular cloning of bone morphogenic protein receptors.J. Bone&Min. Res.8, S145 (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of identifying morphogen receptor-binding analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of identifying morphogen receptor-binding analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying morphogen receptor-binding analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3692765

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.